EUVIMEDEUVIMED entdecken
Open Access

A Rare Treatable Cause of Cardiomyopathy: Primary Carnitine Deficiency

Hacer Basan, Emine Azak, İbrahim İlker Çetin, Esra Kiliç, Berrak Bilginer Gürbüz, Sümeyra Zeynep Özbey, Çiğdem Seher Kasapkara

Molecular Syndromology · 2024 · 15 (2) · 156-160

DOI: 10.1159/000534932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Syndromology, online erschienen am 27.11.2023. Verfasst von Hacer Basan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Department of Pediatric Metabolic Diseases, Ankara City Hospital, Ankara, Turkey. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Primary carnitine deficiency (PCD) is a rare autosomal recessive disorder caused by loss of function mutations in the solute carrier family 22 member 5 (SLC22A5) gene that encodes a high-affinity sodium-ion-dependent organic cation transporter protein (OCTN2). Carnitine deficiency can result in acute metabolic decompensation or, in a more insidious presentation, cardiomyopathy. Cardiomyopathy associated with PCD often presents with life-threatening heart failure. This presentation also usually includes skeletal muscle myopathy. Early recognition of this disorder and treatment with carnitine can avoid life-threatening complications related to cardiomyopathy. Case Presentation: Herein, we present a 10-month-old male patient with PCD, which was diagnosed while investigating the etiology of dilated cardiomyopathy and confirmed by molecular genetic analysis.

Conclusion

Homozygous c.254_265 insGGCTCGCCACC (p.I89Gfs) pathogenic variant of the SLC22A5 gene was detected. With oral L-carnitine supplementation, the free carnitine level increased up to 14 μmol/L and the symptoms disappeared. LVEF increased by 45–70%. We would like to emphasize that this problem is a combination of the metabolic decompensation and the cardiac phenotypes, which are usually separated to either phenotype.

Schlagwörter

Stichwörter der Autor:innen

CardiomyopathyHyperammonemiaPrimary carnitine deficiencySLC22A5 mutation

Autor:innen und Institutionen

  • Department of Pediatrics, Department of Pediatric Metabolic Diseases, Ankara City Hospital, Ankara, Turkey.
  • Department of Pediatrics, Department of Pediatric Cardiology, Ankara City Hospital, Ankara, Turkey.
  • Department of Medical Genetics, Ankara City Hospital, Ankara, Turkey.

Zitieren

APA

Basan, H., Azak, E., Çetin, İ. İ., Kiliç, E., Bilginer Gürbüz, B., Özbey, S. Z., & Kasapkara, Ç. S. (2024). A Rare Treatable Cause of Cardiomyopathy: Primary Carnitine Deficiency. Molecular Syndromology, 15(2), 156-160. https://doi.org/10.1159/000534932

Vancouver

Basan H, Azak E, Çetin İİ, Kiliç E, Bilginer Gürbüz B, Özbey SZ, et al. A Rare Treatable Cause of Cardiomyopathy: Primary Carnitine Deficiency. Molecular Syndromology. 2024;15(2):156-160. doi:10.1159/000534932

BibTeX
@article{Basan2024,
  author = {Basan, Hacer and Azak, Emine and Çetin, İbrahim İlker and Kiliç, Esra and Bilginer Gürbüz, Berrak and Özbey, Sümeyra Zeynep and Kasapkara, Çiğdem Seher},
  title = {A Rare Treatable Cause of Cardiomyopathy: Primary Carnitine Deficiency},
  journal = {Molecular Syndromology},
  year = {2024},
  volume = {15},
  number = {2},
  pages = {156--160},
  doi = {10.1159/000534932}
}
Kostenlos starten →